December 5th-6th 2019
Thursday, november 5th:
- Networking cocktail
Bioethics Workshop 101: Issues and Perspectives in the 21st Century
Pr Yann Joly
Human Genetics Department,
Yann Joly is the research director at the Center for Genomics and Policy (CGP) and Associate Professor in the Department of Human Genetics at McGill University. In addition to having a Ph.D, Pr. Joly is also a lawyer and was awarded the Barreau du Québec’s Avocat émérite distinction in 2012. He is also president of the International Human Epigenome Consortium’s Bioethics Working Group ( IHEC) as well as the Ethics and Governance Committee of the International Cancer Genome Consortium (ICGC). His research interests lie at the crossroads of health law (biotechnology and other emerging health technologies) and bioethics. He has published more than 120 scientifics articles in the fields of law, science and ethics. He also received the prestigious Barreau du Québec’s Merit Award (Innovations) in 2012 for his work in the right to privacy in the biomedical field.
BiogeniQ’s Vice President of Scientific Affairs
Michel Cameron is BiogeniQ’s Vice President of Scientific Affairs since 2014. BiogeniQ is a company dedicated to improving the patient’s treatment and well-being by using their genetic information. He first obtained a master’s degree in biology from the University of Queens and a Ph.D. in pharmacology from the Université de Montréal. He has also completed a post-doctorate at the Montreal Heart Institute and is also Director of Pharmacogenomics at Biron.
Université de Sherbrooke
Benoit Leblanc is a lecturer in the Department of Biology at the Université de Sherbrooke. He is particularly known for the quality of his teaching and his great talents as an popularizer. He participated in the Sherbrooke edition of Pinte de Science in 2016 and led several discussions following the presentation of scientific documentaries (Food Evolution, Giving his body to science). He is also known for his talent as a comic book artist that he shares on his blog (http://gensenblouseblanche.blogspot.com/).
CIUSSS de l’Estrie-CHUS
Annabelle Cumyn is a McGill-certified internal medicine specialist who has been practicing obstetric medicine at CIUSSS in Estrie-CHUS since 2017. She also has a Masters in Health Sciences Pedagogy from the University of Illinois in Chicago. His research interests are in curriculum development and research ethics. She is currently Chair of the Human Health Research Ethics Committee of the CHUS and the Research Ethics Committee (CER) of the CIUSSS of Estrie-CHUS and is a member of the research ethics of the Three Canadian Councils.
Marc-André D’Aoust received his PhD in Plant Biochemistry and Molecular Biology from Université Laval. He started his career at Medicago in 1999 as team manager. He subsequently worked as a product development project director and senior director for research and innovation. He later became Vice President of Research and Innovation at the same company in 2014. He is responsible for overseeing research and development activities related to the vaccine production platform and associated generic technologies. He led the discovery and development of the transient protein expression system, including transient plant-based expression technology, influenza-like particle production, and the VLPExpress high-throughput discovery platform.
Friday, December 6th:
- Plenary conferences
- Oral and poster presentations from students
- Dinner Conference
Guest speakers :
Pr Philippe Gros
Department of Biochemistry,
Professor Philippe Gros has been a professor in the Department of Biochemistry at McGill University since 1993. His research focuses on the study of new genes, proteins or pathways that can lead to complex genetic diseases using murine models, particularly infectious diseases, spina bifida and cancer. It is in fact his research on malaria that allowed him to be part of the 10 discoveries of the year 2018 according to the magazine Quebec Science. To do this, his research team has found a molecule that can fight Plasmodium falciparum and treat cerebral malaria, one of the most dangerous complications of malaria. In addition, he has published over 250 scientific articles in prestigious scientific journals and received the McLaughlin Medal for Scientific Excellence from the Royal Society of Canada in 2014.
Guest speakers :
Pr John Bell
Departments of medicine and biochemistry, microbiology & immunology,
University of Ottawa
John Bell is a professor in the departments of medicine and biochemistry, microbiology & immunology at the University of Ottawa and a senior scientist at the Ottawa Hospital Research Institute. Over the course of the last 30 years, his laboratory has developed a cutting-edge expertise in the use of viruses as treatments against cancer, leading to more than 200 papers published in high impact journals. He also heads the Canadian Oncolytic Virus Consortium, a Terry Fox funded group from across Canada that is developing virus-based cancer therapeutics and is the director of the Biotherapeutics Program for the Ontario Institute for Cancer Research. He is the Scientific Director of the National Centre of Excellence for the development of Biotherapeutics for Cancer Therapy and is a fellow of the Royal Society of Canada.
Organizing committee 2019
The Journée Phare 2019 was organized by a group of graduate students and an associate professor from many fields of study of the Faculty of Medicine and Health Sciences of the University of Sherbrooke, assisted by representatives of other universities.